Abstract Purpose The second International Consensus Conference on B3 lesions was held
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …

OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …

Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …

Lobular neoplasia (LN) is a term that describes the continuum of atypical epithelial lesions
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …

Objectives: Outline the evaluation of atypical breast hyperplasia. Explain the management of
atypical breast hyperplasia. Review the surveillance protocol for patients with atypical breast …

Background Atypical lobular hyperplasia (ALH) is typically diagnosed via needle core
biopsy (NCB) and is commonly removed surgically in light of upgrade to malignancy rates of …

The primary aim of this study was to determine the upgrade rates of variant lobular
carcinoma in situ (V-LCIS, ie, combined florid [F-LCIS] and pleomorphic [P-LCIS]) compared …

Background Atypical lobular hyperplasia (ALH) and classic lobular carcinoma in situ
encompass a spectrum of proliferative lesions known as lobular neoplasia (LN). When …

The management of atypical breast lesions identified on core needle biopsy (CNB) for a
breast imaging abnormality is a topic of controversy. While all these atypical lesions have …

Abstract Purpose of Review Lobular neoplasia is a risk factor for breast cancer development,
but its management remains controversial as upgrade rates differ depending on the subtype …